Cardiac hypoxia can lead to myocardial cell injury by impairing cell viability and increasing oxidative stress. This study evaluates the cytoprotective potential of INNOVA3® Liposomal CoQ10 in H9c2 cardiac cells exposed to hypoxic stress. The findings demonstrate that liposomal CoQ10 significantly improved cardiac cell viability and enhanced antioxidant activity compared with conventional CoQ10. The study highlights the potential of advanced liposomal CoQ10 delivery to enhance cellular protection against hypoxia-induced cardiac injury and support cardioprotective applications in ischemic conditions.